BehyarZoghiMDPhD, FACP
Oncology • San Antonio, TXHematologic Oncology
Bone Marrow Transplant; Hematologist; Medical Oncologist, Assist Prof. of Medicine UT Health & UIW, Chairman of GME at Methodist (2015-2021); Fellow of American College of Physicians, Texas Super Doctor (2018-Present). Arrival Award: Beacon of Light (2019), Early Career Physician Leader of the Year Award Texas Chapter (2019); 2020 Top 20 Impact Maker Award, Castle Connolly Top Doctor 2021-Present
Dr. Zoghi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7700 Floyd Curl Dr
San Antonio, TX 78229Phone+1 210-575-3817Fax+1 210-575-4113
Summary
- Dr. Behyar Zoghi, MD, PhD, FACP is a Transplant Physician, triple Board Certified in Internal Medicine, Hematology and Medical Oncology. He practices with the Adult Blood and Marrow Stem Cell Transplant program at Texas Transplant Institute and Methodist Hospital, a member of the Sarah Cannon Blood Cancer Network.
Dr. Zoghi received both MD and PhD from Texas A&M College of Medicine. He subsequently completed his internship and residency at UT Southwestern Medical Center/Parkland Hospital System in Dallas, and completed his hematology/medical oncology fellowship at the University of Texas Health Science Center at San Antonio.
During his fellowship, Dr. Zoghi conducted very important research focused on microRNA as a new treatment for chemotherapy-resistant breast cancer. He was awarded a patent for this novel therapy in breast cancer, which led to him receiving the Texas Society of Clinical Oncology Award.
His interests include the most recent developments in cancer therapy including immunotherapy, targeted therapy, and CAR-T cell therapy. His holistic approach in cancer therapy was the subject of a cover page article in MD News magazine.
In conjunction with his clinical duties, continual medical education has also been an important passion of Dr. Zoghi. As a Chairman of Graduate Medical Education Committee at Methodist Healthcare System, he was involved in the quality of education and work environment for fellows and residents in all programs from 2015 to 2021. Dr. Zoghi is also an assistant professor of Medicine at the University of Texas Health Science Center at San Antonio.
Dr. Zoghi has numerous awards: Texas Super Doctor (2018-Present), Early Career Physician Leader of the Year Award by American College of Physician; Arrival Award: Beacon of Light (2019), Top 20 Impact Maker Award (2020), Castle Connolly Top Doctor (2021-Present) just to name a few. He has received the distinguished honor of being named Fellow of American College of Physicians.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2008 - 2010- University of Texas Southwestern Medical CenterInternship, Internal Medicine, 2007 - 2008
Texas A&M; Health Science Center College of MedicineClass of 2007
Certifications & Licensure
TX State Medical License 2010 - 2025
CA State Medical License 2016 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctor Castle Connolly, 2021-2023
- Texas Super Doctor 2019-2022
- One of Top 20 Impact Maker Award Houston, Texas, 2020
- Join now to see all
Clinical Trials
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
- Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
- A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease Start of enrollment: 2016 Sep 15
- Join now to see all
Publications & Presentations
PubMed
- 91 citationsThe Involvement of Tyrosine Kinases, Cyclic AMP/Protein Kinase A, and p38 Mitogen-Activated Protein Kinase in IL-13-Mediated Arginase I Induction in Macrophages: Its I...Chiung-I Chang, Behyar Zoghi, James C. Liao, Lih Kuo
Journal of Immunology. 2000-08-15 - 131 citationsBelumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar StudyCorey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi
Blood. 2020-11-05 - 77 citationsROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.Madan Jagasia, Aleksandr Lazaryan, Carlos Bachier, Amandeep Salhotra, Daniel J. Weisdorf
Journal of Clinical Oncology. 2021-04-20
Journal Articles
- Primary Cutaneous Diffuse Large B Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS involvement: from Hospice to RemissionBrenda S. Castillo B.S., Maria Rodriguez, Ju-Hsien John Chao, DO, & Behyar Zoghi, MD, PhD, FACP, Case Reports in Hematology, 2/7/2019
- Spontaneous Resolution of Multiple Hyperpigmented Lesions with Platelet TransfusionBrenda S. Castillo & Behyar Zoghi, International Journal of Clinical & Medical Images, 12/10/2018
- Endocrine therapy for Leptomeningeal Metastases from ER-positive Breast cancer: Case Report and a Review of LiteratureBehyar Zoghi M.D., Ph.D., and Richard Elledge M.D., The Breast Journal, 1/8/2016
- Join now to see all
Abstracts/Posters
- KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) _ Long-Term Follow-up of a Phase 2a Study (KD025-208)Behyar Zoghi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Improving the efficacy if chemotherapy drugs for the treatment of triple-negative breast cancerZoghi B, Ravdin P, Journal of Clinical Oncology
- MicroRNAs as novel therapeutic targets to treat drug-resistant breast cancerChang YF, Zoghi B, Panneerdoss S, Pertsemlidis A, Rao MK, AACR annual meeting
- Join now to see all
Press Mentions
Hearts Need Art Brings Music and Visual Arts to Cancer PatientsJuly 20th, 2018
New Hope for Taming Triple-Negative Breast CancerOctober 2nd, 2012
www.drzoghi.comDecember 19th, 2022
Committees
- American College of Physician, Medical Student Committee Member 2019 - Present
- Member, Clinical Peer Review Committee at Methodist Healthcare System 2015 - Present
- Chairman, Graduate Medical Education at Methodist HealthCare System 2015 - 2021
- Medical Oncologist, Cancer Committee Member at Methodist Hospital 2014 - 2021
Professional Memberships
- Member
- Member
- American Society for Blood and Marrow Transplantation - ASBMTMember
- Member
- Member
- The European Hematology AssociationMember
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
